Home / Products / Cancer (Tumor) Cell Lines / LNCaP-CR
LNCaP-CR
Datasheet Protocol

LNCaP-CR

Cat. No. ARC0455
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Prostate

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

LNCaP-CR is a cancer cell line of prostate carcinoma, isolated from metastatic; left supraclavicular lymph node.

Recommended Products

MFSD6 Knockout NCI-H1975 Polyclonal Cells MFSD6 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16705 GPRIN3 Knockout HGC-27 Polyclonal Cells GPRIN3 Knockout HGC-27 Polyclonal Cells Cat. No. ARG29860 EFCAB14 Knockout A2780 Polyclonal Cells EFCAB14 Knockout A2780 Polyclonal Cells Cat. No. ARG40600 GSR Knockout huh-7 Polyclonal Cells GSR Knockout huh-7 Polyclonal Cells Cat. No. ARG28248 MAFB Knockout HEK293T Polyclonal Cells MAFB Knockout HEK293T Polyclonal Cells Cat. No. ARG3336 ODF2 Knockout Raji Polyclonal Cells ODF2 Knockout Raji Polyclonal Cells Cat. No. ARG1476
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Prostate
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
50 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Left supraclavicular lymph node
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ESPN Knockout NCI-H1299 Polyclonal Cells

ESPN Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG17498
 LACTB2 Knockout jurkat Polyclonal Cells

LACTB2 Knockout jurkat Polyclonal Cells

Cat. No. ARG13192
 C1GALT1 Knockout A2780 Polyclonal Cells

C1GALT1 Knockout A2780 Polyclonal Cells

Cat. No. ARG28943
 MAP3K3 Knockout Hela Polyclonal Cells

MAP3K3 Knockout Hela Polyclonal Cells

Cat. No. ARG7548
 CDKL5 Knockout 786-O Polyclonal Cells

CDKL5 Knockout 786-O Polyclonal Cells

Cat. No. ARG5755
 D283 Med

D283 Med

Cat. No. ARC0159